|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1997-6-11
|
|
pubmed:abstractText |
The addition of omeprazole to 1 week of standard triple therapy (tripotassium dicitrato bismuthate, tetracycline and metronidazole) has given a 98% eradication rate in 54 patients at 4-6 weeks in a research setting. We report the result of a similar 1-week regimen in 52 patients in routine clinical practice assessed at a mean of 8 months.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0269-2813
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
107-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9042981-Adult,
pubmed-meshheading:9042981-Aged,
pubmed-meshheading:9042981-Aged, 80 and over,
pubmed-meshheading:9042981-Anti-Bacterial Agents,
pubmed-meshheading:9042981-Anti-Ulcer Agents,
pubmed-meshheading:9042981-Bismuth,
pubmed-meshheading:9042981-Breath Tests,
pubmed-meshheading:9042981-Drug Therapy, Combination,
pubmed-meshheading:9042981-Female,
pubmed-meshheading:9042981-Helicobacter Infections,
pubmed-meshheading:9042981-Helicobacter pylori,
pubmed-meshheading:9042981-Humans,
pubmed-meshheading:9042981-Male,
pubmed-meshheading:9042981-Metronidazole,
pubmed-meshheading:9042981-Middle Aged,
pubmed-meshheading:9042981-Omeprazole,
pubmed-meshheading:9042981-Organometallic Compounds,
pubmed-meshheading:9042981-Peptic Ulcer,
pubmed-meshheading:9042981-Tetracycline
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
A one-week quadruple eradication regimen for Helicobacter pylori in routine clinical practice.
|
|
pubmed:affiliation |
Department of Medicine, County Hospital, Lincoln, UK.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
